from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3261/fbiA

LFCtreatmentdescriptionclass of inhibitor

0.692

Amikacinug/mL Amikacintranslation

-0.532

Cap5-10ug/mL Capreomycintranslation

0.735

Rox10-50 ug/mL Roxithromycintranslation

-0.165

SM2-5 ug/mL Streptomycintranslation

-0.578

Tet5-10 ug/mL Tetracyclinetranslation

0.708

Rif0.2-5ug/mL Rifampicintranscription

0.727

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.604

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.255

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.724

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.623

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.649

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.666

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.067

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.455

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.626

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.183

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.899

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.598

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.773

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.657

KCN5-20 ug/mL Potassium cyaniderespiration

-1.715

NaN30.2-2 mM Sodium aziderespiration

0.468

Nigericin50 uM Nigericinrespiration

-0.265

TRC10-150 ug/mL Triclosanrespiration

-0.365

TRZ10-25 ug/mL Thioridazinerespiration

-0.650

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.567

menadione6-10 ug/mL Menadionerespiration

-0.291

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.315

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.350

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.168

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.115

NRP_1Non-replicating persistence stage 1dosRassociated

1.371

Amp0.2mg/mL AmpicillincellWall

0.804

Cephalexin20-100 ug/mL CephalexincellWall

0.714

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.276

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.218

EMB10-20 ug/mL EthambutolcellWall

0.913

Eta12-40 ug/mL EthionamidecellWall

1.013

INH0.2-0.4 ug/mL IsoniazidcellWall

0.593

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.319

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.373

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.605

BZA0.12 mg/mL BenzamidearomaticAmides

0.020

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.120

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.171

H2O24 mM hydrogen peroxideDNAdamaging

0.247

Levo10 ug/mL LevofloxacinDNAdamaging

0.235

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.480

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.655

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.034

UVUV-irradiationDNAdamaging

-1.390

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.202

Antimycin12.5-50 ug/mL Antimycin A?

0.181

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.371

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.033

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.164

PA8240.2-2 ug/mL PA-824?

0.321

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.409

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.061

Verapamil50 uM Verapamil?

0.508

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.203

methoxatin10-20 ug/mL Methoxatin?